Pepperminty - the information given on bear's link about Femoston at least is no different from what Mylan themselves have said on the last BMS update except using a new term "supplier allocation". On the BMS info it says this in lay terms ie "shortage of supplies" - but the company has given no additional information. I assume all concerned are just rationing it rather than supplying their limited stocks to just one warehouse or pharmacy ( further down the line).
From our point of view – the most important and relevant information – is that coming from the manufacturers themselves as to what the situation is in terms of delays, production etc.
We know that the last BMS information was 23rd September, but was from their contact with manufacturers – so this is as up to date as we have. I would have thought the companies would highlight where projected shortages are likely to occur? Regarding Mylan's products (mentioned by bear), the BMS quoted detailed information from this company (and others where available) about what they were doing re the shortages in terms of manufacturing – so I'll reproduce it here:
“
Earlier this year, Mylan was experiencing an interruption in the production of Ellesteâ„¢, which included; Elleste Soloâ„¢ (1mg & 2mg), Elleste Duetâ„¢ (1mg & 2mg) and Elleste Duetâ„¢ Conti (2mg).
At that time, Mylan anticipated a temporary interruption and for stock levels to resume during the middle of 2019. To minimise disruption to patients and to support pharmacies, societies and healthcare professionals (HCPs) across the country Mylan took several proactive steps, including:
• sending two Elleste™ stock constraint mailers to 50,000+ HCPs;
• informing the British Menopause Society;
• continuously communicating with the National Pharmacy Association; and
• creating a MyWay Pharmacist leaflet for our salesforce to use when visiting pharmacists across the country.
In addition, Mylan created a new promotional page on its dedicated HCP website, called MyWay HRT Overview and Stock Availability. This page provides details of Mylan range of HRT products, stock availability and options to switch patients to alternative products where appropriate.
To ensure the stable supply of Ellesteâ„¢ Oral Tablets in the future, Mylan will be transferring the production of Ellesteâ„¢ to a Mylan owned and operated facility.
The site transfer is in progress and Myaln anticipate production to resume by second half of 2020. In the meantime, any stock of Ellesteâ„¢ Oral Tablets in the market, is available to order and prescribe. Once that supply has been depleted, the replenishment of Ellesteâ„¢ Oral Tablets will not be available until the site transfer process has been completed.
Mylan will continue to support pharmacies, societies and healthcare professionals by providing updates on materials and communications including updates to stock availability, timing for resolution and information about Mylan's other HRT products.
Please note that this does not affect the transdermal patches; Elleste Soloâ„¢ MX (40 and 80mcg).
Mylan has a dedicated website for healthcare professionals, which has LIVE information about current supply of their HRT. The overview of stock availability page can be accessed on: https://mywayhub.co.uk/en-gb/range
Mylan HRT stock can only be obtained through AAH, Alliance and Phoenix
If you have difficulty obtaining supplies please contact Mylan Customer Service on:
[email protected]â€
So - we know what's happening with Elleste at least.
As you can see from the above, the company is also giving live updates for their products (Elleste solo, Elleste Duet and Femoston) on a dedicated website (link above). You can see at a glance which products are in stock. They have also provided detailed information about the production of their products and the timescale and this is what was communicated to the BMS (as above). Therefore the most up-to-date info re Mylan at least can be obtained directly from them without waiting for BMS.
Some of the other comapnies do not appear to be clear about their products - for example Novartis - to whom several have written but with unsatisfactory responses. I posted on another thread ( I think!) about what they said - I wrote back but did not hear again....they are all probably inundated.
Re bear's link to Aah stock. It looks like they are one of our wholesalers referred to in the pharmacy blog I linked to in previous post (and which Mylan refer to...)– extract below:
“Between the two main wholesalers in the UK, there are nearly 30 warehouses serving the whole country. When patients are informed of a shortage by their pharmacist, it's because there may be stock of the item somewhere in the supply system but not in the depot local to the pharmacy placing the order, which means it can't be ordered.â€
Like I said in a previous post – it is clear that due to the complexity of the supply chain even if one organisation is out of stock – it may be in stock still somewhere in the supply chain until – if there is a manufacturing delay – it runs out. This is why there are such inconsistencies across the country Grrr!
Happy days
Hurdity x
Author
Topic: HRT supply issues update on all Products see link (Read 112680 times)